Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Search
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)
Hang Seng
17,417.68
(-2.03%)
Dow Jones
40,287.53
(-0.93%)
Nikkei 225
40,063.79
(-0.16%)
FTSE 100
8,155.72
(-0.6%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
66,838.08
(0.44%)
Oil
80.25
(-3.1%)
Gold
2,402.80
(-2.18%)
Lithium
41.42
(1.37%)
Iron Ore
104.4
(-1.03%)

Island Pharmaceuticals (ASX: $ILA) doses third cohort in ISLA-101 study

Island Pharmaceuticals (ASX: $ILA) Third Cohort Dosed in ISLA-101 Study


Island Pharmaceuticals Ltd (ASX: $ILA) has successfully dosed all eight subjects in the third cohort of its Single Ascending Dose study with ISLA-101. The dosing followed confirmation by the Safety Review Committee that the second cohort of healthy subjects demonstrated good tolerability to ISLA-101. Pending review of cohort 3 results, the cohort who received the highest safe dose will return to be treated under fed conditions for final dosing. Island remains on track to report trial data in early 2024.

Executive Commentary on ISLA-101 Study Progress


CEO of Island Pharmaceuticals, Dr David Foster said, 'We are very pleased with how this study is progressing and thank all those volunteers participating in it. With the dose now administered to the third cohort, we are moving swiftly toward the completion of dosing for this study. Based on our current progress, we remain on track to read out data in early 2024.'

Summary of Island Pharmaceuticals' ISLA-101 Study


Island Pharmaceuticals Ltd (ASX: $ILA) has successfully dosed the third cohort in its Single Ascending Dose study with ISLA-101, following confirmation of good tolerability in the second cohort. Pending review of cohort 3 results, the highest safe dose cohort will return for final dosing under fed conditions. The company remains on track to report trial data in early 2024. ISLA-101, a repurposed drug candidate for the prevention and treatment of dengue fever and other mosquito-borne diseases, is progressing towards the completion of dosing for the study, paving the way for Island's planned Phase 2a PEACH clinical trial.

Sourcehttps://announcements.asx.com.au/asxpdf/20240119/pdf/05zkpt0ry9pjvh.pdf

Share to Social
0 Comments
Inline Feedbacks
View all comments

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions